Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

To identify drugs that are potentially used for the treatment of COVID-19, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay. Four compounds, Clomiphene (citrate), Vortioxetine, Vortioxetine...

Full description

Bibliographic Details
Main Authors:	Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, Sheng-Xiang Ge, Hui-Ming Ye, Jun Zhang, Quan Yuan, Tian-Ying Zhang, Ning-Shao Xia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Pharmacology
Subjects:	drug screening SARS-CoV-2 pseudovirus assay vesicular stomatitis virus drug combination
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.609592/full

Similar Items

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
by: Hua-Long Xiong, et al.
Published: (2020-01-01)

Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay
by: Sarah A. Almahboub, et al.
Published: (2020-09-01)

Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
by: Marcela Salazar-García, et al.
Published: (2022-01-01)

HIV-1 pseudoviruses constructed in China regulatory laboratory
by: Jianhui Nie, et al.
Published: (2020-01-01)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
by: Cecilia Vial, et al.
Published: (2020-09-01)

A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018-12-01)

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus
by: Jinhao Bi, et al.
Published: (2022-06-01)

First case report of vesicular stomatitis in the State of Paraíba, Brazil
by: Inácio José Clementino, et al.
Published: (2014-10-01)

A method for the generation of pseudovirus particles bearing SARS coronavirus spike protein in high yields
by: Yoichiro Fujioka, et al.
Published: (2022-04-01)

Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine
by: Gary Wong
Published: (2019-08-01)

Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins
by: Maria Fernanda Lay Mendoza, et al.
Published: (2020-12-01)

Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies
by: Mami Matsuda, et al.
Published: (2024-01-01)

Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant
by: Wenwen He, et al.
Published: (2023-02-01)

Full Genomic Sequencing of Vesicular Stomatitis Virus Isolates from the 2004–2006 US Outbreaks Reveals Associations of Viral Genetics to Environmental Variables
by: Rachel Palinski, et al.
Published: (2020-06-01)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
by: Katherine E. Havranek, et al.
Published: (2021-12-01)

Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies
by: Darija Muharemagic, et al.
Published: (2014-01-01)

Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
by: Qiang Hu, et al.
Published: (2023-03-01)

A Fluorescent Real-Time Plaque Assay Enables Single-Cell Analysis of Virus-Induced Cytopathic Effect by Live-Cell Imaging
by: Jorge L. Arias-Arias, et al.
Published: (2021-06-01)

Mapping the Interface between New World Hantaviruses and Their Receptor, PCDH1
by: Megan M. Slough, et al.
Published: (2020-06-01)

Molecular Tracking of the Origin of Vesicular Stomatitis Outbreaks in 2004 and 2018, Ecuador
by: David Vasco-Julio, et al.
Published: (2023-02-01)

Producing Vesicular Stomatitis Virus G (VSVG) Protein and Assessment of its Cytotoxic Activity against Breast Cancer Cells
by: Fereshteh Ghandehari, et al.
Published: (2015-05-01)

Development and applications of VSV vectors based on cell tropism
by: Hideki eTani, et al.
Published: (2012-01-01)

The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion
by: Emmanuel Heilmann, et al.
Published: (2019-10-01)

Interferon Response and Viral Evasion by Members of the Family Rhabdoviridae
by: Matthias J. Schnell, et al.
Published: (2009-11-01)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)

Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for Targeting
by: Manisha Pandey, et al.
Published: (2021-11-01)

In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria
by: Lucie Peyclit, et al.
Published: (2022-02-01)

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
by: Longbo Hu, et al.
Published: (2023-07-01)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
by: Ziteng Liang, et al.
Published: (2023-12-01)

Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats
by: Xiaojuan Xue, et al.
Published: (2021-01-01)

Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses
by: Danielle Blondel, et al.
Published: (2015-07-01)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
by: Janine Kimpel, et al.
Published: (2018-03-01)

Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
by: Lisa Pipperger, et al.
Published: (2021-01-01)

Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
by: Ziteng Liang, et al.
Published: (2024-04-01)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01)

RIG‐I‐mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virus
by: Pengfei Zhang, et al.
Published: (2023-01-01)

Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein
by: Yang Zhu, et al.
Published: (2019-05-01)

A Natural Botanical Product, Resveratrol, Effectively Suppresses Vesicular Stomatitis Virus Infection In Vitro
by: Shih-Chao Lin, et al.
Published: (2021-06-01)

Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
by: Wei-Wei Jia, et al.
Published: (2022-12-01)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
by: Hancong Sun, et al.
Published: (2022-06-01)